Imagine taking three different pills for your diabetes, but your blood sugar still isn't where it needs to be. What's the next step? A new study tested two common choices: adding a fourth type of oral medication versus just increasing the dose of the metformin you're already on.
The trial involved 193 adults whose blood sugar (measured by HbA1c) was still too high despite being on three different diabetes pills. After 24 weeks, the group that got a fourth pill saw a greater drop in their HbA1c. Nearly 70% of them reached the target blood sugar level, compared to about 48% in the group that just got more metformin. The four-drug approach also showed signs of improving how the body uses insulin and reducing a marker of kidney stress, though the exact size of these benefits wasn't measured.
Importantly, side effects were described as mild and similar between the two groups. However, this was an open-label study, meaning everyone knew which treatment they were getting, which can sometimes influence results. We also don't know the specific safety event rates or what happened after the 24-week study period ended. The findings support the idea of a four-pill strategy as a potential next move, but more research is needed to understand the long-term picture.